The Faculty of Medicine - Biochemistry and Molecular Biology: Rones Zichria

(1) Alfi O, Hamdan M, Wald O, Yakirevitch A, Wandel O, Oiknine-Djian E, et al. SARS-CoV-2 Omicron Induces Enhanced Mucosal Interferon Response Compared to other Variants of Concern, Associated with Restricted Replication in Human Lung Tissues. Viruses 2022;14(7).

(2) Vorontsov O, Levitt L, Lilleri D, Vainer GW, Kaplan O, Schreiber L, et al. Amniotic fluid biomarkers predict the severity of congenital cytomegalovirus infection. J Clin Invest 2022;132(11).

(3) Alfi O, Yakirevitch A, Wald O, Wandel O, Izhar U, Oiknine-Djian E, et al. Human nasal and lung tissues infected ex vivo with SARS-CoV-2 provide insights into differential tissue-specific and virus-specific innate immune responses in the upper and lower respiratory tract. J Virol 2021;95(14).

(4) Alfi O, From I, Yakirevitch A, Drendel M, Wolf M, Meir K, et al. Human nasal turbinate tissues in organ culture as a model for human cytomegalovirus infection at the mucosal entry site. J Virol 2020;94(19).

(5) Weisblum Y, Oiknine-Djian E, Vorontsov OM, Haimov-Kochman R, Zakay-Rones Z, Meir K, et al. Erratum: Correction for Weisblum et al., "zika virus infects early-and midgestation human maternal decidual tissues, inducing distinct innate tissue responses in the maternal-fetal interface(Journal of Virology (2017) 91:4 (e01905-e01916) DOI: 10.1128/JVI.01905-16). J Virol 2019;93(22).

(6) Weisblum Y, Oiknine-Djian E, Zakay-Rones Z, Vorontsov O, Haimov-Kochman R, Nevo Y, et al. APOBEC3A is upregulated by human cytomegalovirus (HCMV) in the maternal-fetal interface, acting as an innate anti-HCMV effector. J Virol 2017;91(23).

(7) Neto CC, Penndorf KA, Feldman M, Meron-Sudai S, Zakay-Rones Z, Steinberg D, et al. Characterization of non-dialyzable constituents from cranberry juice that inhibit adhesion, co-aggregation and biofilm formation by oral bacteria. Food Funct 2017;8(5):1955-1965.

(8) Weisblum Y, Oiknine-Djian E, Vorontsov OM, Haimov-Kochman R, Zakay-Rones Z, Meir K, et al. Zika virus infects early- and midgestation human maternal decidual tissues, inducing distinct innate tissue responses in the maternal-fetal interface. J Virol 2017;91(4).

(9) Weisblum Y, Panet A, Zakay-Rones Z, Vitenshtein A, Haimov-Kochman R, Goldman-Wohl D, et al. Human cytomegalovirus induces a distinct innate immune response in the maternal-fetal interface. Virology 2015;485:289-296.

(10) Yaacov B, Lazar I, Tayeb S, Frank S, Izhar U, Lotem M, et al. Extracellular matrix constituents interfere with Newcastle disease virus spread in solid tissue and diminish its potential oncolytic activity. J Gen Virol 2012;93(8):1664-1672.

(11) Oiknine-Djian E, Houri-Haddad Y, Weiss E, Ofek I, Greenbaum E, Hartshorn K, et al. High molecular weight constituents of cranberry interfere with influenza virus neuraminidase activity in vitro. Planta Med 2012;78(10):962-967.

(12) Shmuely H, Ofek I, Weiss EI, Rones Z, Houri-Haddad Y. Cranberry components for the therapy of infectious disease. Curr Opin Biotechnol 2012;23(2):148-152.

(13) Hojsak I, Avitzur Y, Mor E, Shamir R, Haimi-Cohen Y, Zakay-Rones Z, et al. Antibody response to influenza vaccine in pediatric liver transplant recipients. Pediatr Infect Dis J 2011;30(6):491-494.

(14) Engelhard D, Zakay-Rones Z, Shapira MY, Resnick I, Averbuch D, Grisariu S, et al. The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic. Vaccine 2011;29(9):1777-1782.

(15) Zakay-Rones Z. Human influenza vaccines and assessment of immunogenicity. Expert Rev Vaccines 2010;9(12):1423-1439.

(16) Lazar I, Yaacov B, Shiloach T, Eliahoo E, Kadouri L, Lotem M, et al. The oncolytic activity of Newcastle disease virus NDV-HUJ on chemoresistant primary melanoma cells is dependent on the proapoptotic activity of the inhibitor of apoptosis protein livin. J Virol 2010;84(1):639-646.

(17) Cohen-Daniel L, Zakay-Rones Z, Resnick IB, Shapira MY, Dorozhko M, Mador N, et al. Emergence of oseltamivir-resistant influenza A/H3N2 virus with altered hemagglutination pattern in a hematopoietic stem cell transplant recipient. J Clin Virol 2009;44(2):138-140.

(18) Yaacov B, Elihaoo E, Lazar I, Ben-Shlomo M, Greenbaum I, Panet A, et al. Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors (Cancer Gene Therapy (2008) 15, (795-807) DOI: 10.1038/cgt.2008.31). Cancer Gene Ther 2008;15(12):832.

(19) Yaacov B, Elihaoo E, Lazar I, Ben-Shlomo M, Greenbaum I, Panet A, et al. Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors. Cancer Gene Ther 2008;15(12):795-807.

(20) Gazit R, Gruda R, Elboim M, Arnon TI, Katz G, Achdout H, et al. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol 2006;7(5):517-523.

(21) Muhamed G, Greenbaum E, Zakay-Rones Z. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination. Isr Med Assoc J 2006;8(3):155-158.

(22) Freeman AI, Zakay-Rones Z, Gomori JM, Linetsky E, Rasooly L, Greenbaum E, et al. Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme. Mol Ther 2006;13(1):221-228.

(23) Paritsky M, Raz R, Zakay-Rones Z, Flatau E. Incidence of influenza among patients admitted to the Department of Internal Medicine during the winter season. Harefuah 2005;144(10):689-691.

(24) Weiss EI, Houri-Haddad Y, Greenbaum E, Hochman N, Ofek I, Zakay-Rones Z. Cranberry juice constituents affect influenza virus adhesion and infectivity. Antiviral Res 2005;66(1):9-12.

(25) Wolf DG, Rekhtman D, Kerem E, Hay A, Mador N, Greenbaum E, et al. A summer outbreak of influenza A virus infection among young children. Clin Infect Dis 2004;39(4):595-597.

(26) Greenbaum E, Engelhard D, Levy R, Schlezinger M, Morag A, Zakay-Rones Z. Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine. Vaccine 2004;22(20):2566-2577.

(27) Zakay-Rones Z, Thom E, Wollan T, Wadstein J. Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections. J Int Med Res 2004;32(2):132-140.

(28) Greenbaum E, Nir-Paz R, Linton DM, Ben-Hur T, Meirovitz A, Zakay-Rones Z. Severe influenza infection in a chronic hepatitis C carrier: Failure of protective serum HI antibodies after IM vaccination. J Clin Virol 2004;29(1):23-26.

(29) Wolf DG, Zakay-Rones Z, Fadeela A, Greenberg D, Dagan R. High Seroprevalence of Human Metapneumovirus among Young Children in Israel. J Infect Dis 2003;188(12):1865-1867.

(30) Bronstein-Sitton N, Cohen-Daniel L, Vaknin I, Ezernitchi AV, Leshem B, Halabi A, et al. Sustained exposure to bacterial antigen induces interferon-γ-dependent T cell receptor ζ down-regulation and impaired T cell function. Nat Immunol 2003;4(10):957-964.

(31) Ben-Yehuda A, Joseph A, Barenholz Y, Zeira E, Even-Chen S, Louria-Hayon I, et al. Immunogenicity and safety of a novel IL-2-supplemented liposomal influenza vaccine (INFLUSOME-VAC) in nursing-home residents. Vaccine 2003;21(23):3169-3178.

(32) Ben-Yehuda A, Joseph A, Zeira E, Even-Chen S, Louria-Hayon I, Babai I, et al. Immunogenicity and safety of a novel liposomal influenza subunit vaccine (INFLUSOME-VAC) in young adults. J Med Virol 2003;69(4):560-567.

(33) Muszkat M, Greenbaum E, Ben-Yehuda A, Oster M, Yeu'l E, Heimann S, et al. Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine. Vaccine 2003;21(11-12):1180-1186.

(34) Muszkat M, Friedman G, Dannenberg HD, Greenbaum E, Lipo M, Heymann Y, et al. Response to influenza vaccination in community and in nursing home residing elderly: Relation to clinical factors. Exp Gerontol 2003;38(10):1199-1203.

(35) Joseph A, Louria-Hayon I, Plis-Finarov A, Zeira E, Zakay-Rones Z, Raz E, et al. Liposomal immunostimulatory DNA sequence (ISS-ODN): An efficient parenteral and mucosal adjuvant for influenza and hepatitis B vaccines. Vaccine 2002;20(27-28):3342-3354.

(36) Kiderman A, Furst AL, Miller T, Schmidt-Afek N, Morag A, Zakay-Rones Z. How successfully do general practitioners diagnose herpetic gingivo-stomatitis clinically? Br J Gen Pract 2002;52(479):481-482.

(37) Greenbaum E, Furst A, Kiderman A, Stewart B, Levy R, Schlesinger M, et al. Mucosal [SIgA] and serum [IgG] immunologic responses in the community after a single intra-nasal immunization with a new inactivated trivalent influenza vaccine. Vaccine 2002;20(7-8):1232-1239.

(38) Isacsohn M, Smetana Z, Rones ZZ, Raveh D, Diamant Y, Samueloff A, et al. A sero-epidemiological study of herpes virus type 1 and 2 infection in Israel. J Clin Virol 2002;24(1-2):85-92.

(39) Babai I, Barenholz Y, Zakay-Rones Z, Greenbaum E, Samira S, Hayon I, et al. A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains. Vaccine 2001;20(3-4):505-515.

(40) Greenbaum E, Furst A, Kiderman A, Stewart B, Levy R, Schlesinger M, et al. Area under the viraemia curve versus absolute viral load: Utility for predicting symptomatic cytomegalovirus infections in kidney transplant patients. J Med Virol 2001;65(1):85-89.

(41) Van Slooten ML, Hayon I, Babai I, Zakay-Rones Z, Wagner E, Storm G, et al. Immunoadjuvant activity of interferon-γ-liposomes co-administered with influenza vaccines. Biochim Biophys Acta Mol Cell Biol Lipids 2001;1531(1-2):99-110.

(42) Heling I, Morag-Hezroni M, Marva E, Hochman N, Zakay-Rones Z, Morag A. Is herpes simplex virus associated with pulp/periapical inflammation? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91(3):359-361.

(43) Kiderman A, Furst A, Stewart B, Greenbaum E, Morag A, Zakay-Rones Z. A double-blind trial of a new inactivated, trivalent, intra-nasal anti-influenza vaccine in general practice: Relationship between immunogenicity and respiratory morbidity over the winter of 1997-98. J Clin Virol 2001;20(3):155-161.

(44) Muszkat M, Ben Yehuda A, Schein MH, Friedlander Y, Naveh P, Greenbaum E, et al. Local and systemic immune response in community-dwelling elderly after intranasal or intramuscular immunization with inactivated influenza vaccine. J Med Virol 2000;61(1):100-106.

(45) Muszkat M, Friedman G, Schein MH, Naveh P, Greenbaum E, Schlesinger M, et al. Local SIgA response following administration of a novel intranasal inactivated influenza virus vaccine in community residing elderly. Vaccine 2000;18(16):1696-1699.

(46) Babai I, Samira S, Barenholz Y, Zakay-Rones Z, Kedar E. A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in mice. Vaccine 1999;17(9-10):1239-1250.

(47) Babai I, Samira S, Barenholz Y, Zakay-Rones Z, Kedar E. A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice. Vaccine 1999;17(9-10):1223-1238.

(48) Morecki S, Nagler A, Zakay-Rones Z, Schlesinger M, Lubina-Salomon A, Pugatsch T, et al. Tumorigenicity and immunogenicity in a murine model of B-cell leukemia/lymphoma (BCL1). Leuk Res 1998;22(9):831-835.

(49) Ben-Yehuda A, Danenberg HD, Zakay-Rones Z, Gross DJ, Friedman G. The influence of sequential annual vaccination and of DHEA administration on the efficacy of the immune response to influenza vaccine in the elderly. Mech Ageing Dev 1998;102(2-3):299-306.

(50) Samina I, Zakay-Rones Z, Peleg B-. Homologous and heterologous antibody response of cattle and sheep after vaccination with foot and mouth disease and influenza viruses. Vaccine 1998;16(6):551-557.

(51) Hochman N, Zakay-Rones Z, Shohat H, Ever-Hadani P, Ehrlich J, Schlesinger M, et al. Antibodies to cytomegalo and Epstein-Barr viruses in human saliva and gingival fluid. New Microbiol 1998;21(2):131-139.

(52) Samina I, Zakay-Rones Z, Weller JI, Peleg B-. Host factors affecting the homologous and heterologous immune response of cattle to FMDV: Genetic background, age, virus strains and route of administration. Vaccine 1998;16(4):335-339.

(53) Greenbaum E, Morag A, Zakay-Rones Z. Isolation of influenza C virus during an outbreak of influenza A and B viruses. J Clin Microbiol 1998;36(5):1441-1442.

(54) Danenberg HD, Ben-Yehuda A, Zakay-Rones Z, Gross DJ, Friedman G. Dehydroepiandrosterone treatment is not beneficial to the immune response to influenza in elderly subjects. J Clin Endocrinol Metab 1997;82(9):2911-2914.

(55) Abdul-Hai A, Ben-Yehuda A, Weiss L, Friedman G, Zakay-Rones Z, Slavin S, et al. Interleukin-7-enhanced cytotoxic T lymphocyte activity after viral infection in marrow transplanted mice. Bone Marrow Transplant 1997;19(6):539-543.

(56) Admon D, Engelhard D, Strauss N, Goldman N, Zakay-Rones Z. Antibody response to influenza immunization in patients after heart transplantation. Vaccine 1997;15(14):1518-1522.

(57) Magdassi S, Toledano O, Zakay-Rones Z. Solubilization in colloidal immunoclusters. J Colloid Interface Sci 1996;184(2):360-364.

(58) Mumcuoglu M, Zakay-Rones Z, Weiss L, Slavin S. Enhancement of primary and secondary responses to sheep red blood cells and influenza virus in BALB/c mice by recombinant human interleukin-2. Exp Hematol 1996;24(13):1516-1520.

(59) Bar-Eli N, Giloh H, Schlesinger M, Zakay-Rones Z. Preferential cytotoxic effect of Newcastle disease virus on lymphoma cells. J Cancer Res Clin Oncol 1996;122(7):409-415.

(60) Zakay-Rones Z, Varsano N, Zlotnik M, Manor O, Regev L, Schlesinger M, et al. Inhibition of Several Strains of Influenza Virus in Vitro and Reduction of Symptoms by an Elderberry Extract (Sambucus nigra L.) during an Outbreak of Influenza B Panama. J Altern Complement Med 1995;1(4):361-369.

(61) Tzadok-David Y, Metzkin-Eizenberg M, Zakay-Rones Z. The effect of a mesogenic and a lentogenic Newcastle disease virus strain on Burkitt lymphoma Daudi cells. J Cancer Res Clin Oncol 1995;121(3):169-174.

(62) DANENBERG HD, BEN‐YEHUDA A, ZAKAY‐RONES Z, FRIEDMAN G. Dehydroepiandrosterone Enhances Influenza Immunization in Aged Mice. Ann New York Acad Sci 1995;774(1):297-299.

(63) Morag A, Abed Y, Schoub BD, Lifshitz A, Zakay-Rones Z. Enteric viral infections in Gaza children - Incidence and associated factors and phenomena. Isr J Med Sci 1995;31(1):49-53.

(64) Danenberg HD, Ben-Yehuda A, Zakay-Rones Z, Friedman G. Dehydroepiandrosterone (DHEA) treatment reverses the impaired immune response of old mice to influenza vaccination and protects from influenza infection. Vaccine 1995;13(15):1445-1448.

(65) Magdassi S, Toledano O, Zakay-Rhones Z. Formation of novel colloidal immunoclusters by surface active antibodies. J Colloid Interface Sci 1995;175(2):435-439.

(66) Hochman N, Mizrachi E, Ehrlich J, Morag A, Schlesinger M, Ever-Hadani P, et al. Prevalence of viral antibodies in gingival crevicular fluid. New Microbiol 1994;17(2):75-84.

(67) Engelhard D, Nagler A, Hardan I, Morag A, Aker M, Baciu H, et al. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant 1993;11(1):1-5.

(68) Amit R, Morag A, Ravid Z, Hochman N, Ehrlich J, Zakay-Rones Z. Detection of herpes simplex virus in gingival tissue. J Periodontol 1992;63(6):502-506.

(69) Leshem B, Dekel R, Bercovier H, Tchakirov R, Polacheck I, Zakay-Rones Z, et al. Cytokine-induced resistance to microbial infections in normal, immunosuppressed and bone marrow transplanted mice. Bone Marrow Transplant 1992;9(6):471-477.

(70) Grunwald-Beard L, Gamliel H, Parag G, Vedantham S, Zakay-Rones Z. Killing of burkitt-lymphoma-derived daudi cells by ultraviolet-inactivated vaccinia virus. J Cancer Res Clin Oncol 1991;117(6):561-567.

(71) Huminer D, Pitlik SD, Katz A, Metzker A, David M, Zimran A, et al. Untoward effects of gas masks during Persian Gulf war. New Engl J Med 1991;325(8):582-583.

(72) Weil-Hillman G, Levi R, Zakay-Rones Z. Increase in concanavalin A cap formation on lymphoma cells following interaction with inactive influenza viruses. Acta Virol 1991;35(3):238-246.

(73) Mumcuoglu M, Zakay-Rones Z, Weiss L, Slavin S. The effect of total or partial T lymphocyte depletion on susceptibility to influenza virus infection and development of antiviral immunity in lethally irradiated mice reconstituted with immune syngeneic bone marrow grafts. Bone Marrow Transplant 1991;7(3):217-220.

(74) Shoham J, Hirsch R, Zakay-Rones Z, Osband ME, Brennert HJ. Augmentation of tumor cell immunogenicity by viruses - an approach to specific immunotherapy of cancer1. Nat Immun Cell Growth Regul 1990;9(3):165-172.

(75) Shlomi Y, Zakay-Rones Z. Sensitivity of Burkitt lymphoma Daudi cells to inactive influenza virus. J Cancer Res Clin Oncol 1989;115(3):308.

(76) Shlomi Y, Zakay-Rones Z. Sensitivity of Burkitt lymphoma Daudi cells to inactive influenza virus. J Cancer Res Clin Oncol 1989;115(1):61-66.

(77) Zakay‐Rones Z, Meijer A, Morag A. Prevalence of antibody to current influenza virus strains in adolescents. J Med Virol 1989;29(4):308-310.

(78) Hochman N, Ehrlich J, Zakay-Rones Z. Oral cavity herpes simplex virus--a risk factor to dental personnel and patients. An overview. Isr J Dent Sci 1989;2(3):158-161.

(79) Slosaris M, Levy B, Katz E, Levy R, Zakay-Rones Z. Elevated virulence of Newcastle disease virus strains following serial passages in kidney cells in vitro. Avian Dis 1989;33(2):248-253.

(80) Keren G, Segev S, Morag A, Zakay‐Rones Z, Barzilai A, Rubinstein E. Failure of influenza vaccination in the aged. J Med Virol 1988;25(1):85-89.

(81) Meijer A, Zakay‐Rones Z, Morag A. Post‐influenzal psychiatric disorder in adolescents. Acta Psychiatr Scand 1988;78(2):176-181.

(82) Mumcuoglu M, Zakay-Rones Z, Parag G, Weiss L, Slavin S. The effect of T lymphocyte depletion on susceptibility to influenza virus infection and development of anti-viral immunity in lethally irradiated mice reconstituted with syngeneic bone marrow grafts. Bone Marrow Transplant 1987;2(4):403-412.

(83) Weil-Hillman G, Zakay-Rones Z. Inhibition of Daudi tumor formation by inactive influenza virus in a nude mouse model. Cancer J 1987;1(5):208-213.

(84) Zakay-Rones Z, Ehrlich J, Hochman N, Levy R. Hypothesis: the gingival tissue as a reservoir for herpes simplex virus. Microbiologica 1986;9(3):367-371.

(85) Weil-Hillman G, Zakay-Rones Z. ARREST OF DAUDI CELL GROWTH BY INACTIVE INFLUENZA VIRUS IN-VITRO. Scanning Electron Microsc 1985;v:1679-1686.

(86) Weil-Hillman G, Gamliel H, Friedmann A, Zakay-Rones Z. VISUALIZATION OF THE FATE OF INACTIVE INFLUENZA VIRUSES IN DAUDI CELLS BY ELECTRON MICROSCOPY. Scanning Electron Microsc 1985;v:1687-1693.

(87) Shapira‐Nahor O, Zakay‐Rones Z. Local and peripheral cell‐mediated immune response to influenza virus in mice. J Med Virol 1985;15(1):81-91.

(88) Taya M, Morag A, Abramowitz A, Goldblum N, Zakay-Rones Z. Prevalence of antibodies to respiratory syncytial virus in various populations in Israel. Isr J Med Sci 1984;20(12):1146-1149.

(89) Morag A, Levy R, Weil G, Zakay‐Rones Z. Clinical and serological response in humans following immunization with gripax influenza vaccine. J Med Virol 1983;11(1):67-75.

(90) Rones Y, Hochman N, Ehrlich J, Zakay Rones Z. Sensitivity of oral tissues to herpes simplex virus in vitro. J Periodontol 1983;54(2):91-95.

(91) Levy R, Zakay‐Rones Z. Preparation and evaluation of a zonal purified influenza vaccine gripax. J Med Virol 1982;10(4):265-272.

(92) Zakay Rones Z, Hochman N, Rones Y. Immunological response to herpes simplex virus in human gingival fluid. J Periodontol 1982;53(1):42-45.

(93) Shapira‐Nahor O, Morag A, Levy R, Zakay‐Rones Z. Cellular response in humans following vaccination with gripax influenza virus. J Med Virol 1982;10(1):75-80.

(94) Hochman N, Rones Y, Ehrlich J, Levy R, Zakay-Rones Z. Antibodies to herpes simplex virus in human gingival fluid. J Periodontol 1981;52(6):324-327.

(95) Zakay-Rones Z, Margalith E, Levy R, Katz E. A sensitive plaque inhibition technique for assay of antibodies to influenza virus: Use to detect previous antigenic priming with influenza viruses. J Virol Methods 1980;1(6):355-360.

(96) Zakay-Rones Z, Hadas O, Levy R. Modulation of the lung local immune response by systemic immunization. Med Microbiol Immunol 1978;166(1-4):43-50.

(97) Spira G, Silvian I, Zakay Rones Z. Iodination of Newcastle disease virus envelope proteins with lactoperoxidase. Isr J Med Sci 1977;13(1):76-80.

(98) Spira G, Silvian I, Zakay Rones Z. Radioimmunoassay for detection of antigen and antibodies to Newcastle disease virus. J Immunol 1976;116(4):1089-1092.

(99) Levy R, Spira G, Zakay-Rones Z. Newcastle disease virus pathogenesis in the respiratory tract of local or systemic immunized chickens. Avian Dis 1975;19(4):700-706.

(100) Zakay-Rones Z, Spira G, Levy R. Local antibody formation in the brain of chickens. Archiv f Virusforschung 1974;45(3):290-293.

(101) Zakay Rones Z, Levy R. Immunologic response of chicks to inactivated Newcastle disease virus. Avian Dis 1973;17(2):450-452.

(102) Levy R, Zakay Rones Z. Immunization of chickens with an inactivated oil adjuvant Newcastle disease virus vaccine. Avian Dis 1973;17(3):598-604.

(103) Zakay Rones Z, Ehrlich J, Hochman N, Levy R. The sulcular epithelium as a reservoir for Herpes Simplex Virus in man. J Periodontol 1973;44(12):779-781.

(104) Maythar B, Zakay-Rones Z. Local and humoral chlamydial antibodies in trachoma patients of different age groups. Invest Ophthalmol 1972;11(8):651-654.

(105) Zakay-Rones Z, Levy R, Spira G. Secretory Newcastle disease virus antibodies from chicken respiratory tract. J Immunol 1972;109(2):311-316.

(106) Zakay-Rones Z, Levy R, Maythar B. Local antibodies to trachoma agent. Isr J Med Sci 1972;8(8):1130-1133.

(107) Becker Y, Asher Y, Zakay-Rones Z. Congocidine and distamycin A, antipoxvirus antibiotics. Antimicrob Agents Chemother 1972;1(6):483-488.

(108) Zakay-Rones Z, Spira G, Levy R. Local immunologic response to immunization with inactivated Newcastle disease virus. J Immunol 1971;107(4):1180-1183.

(109) Becker Y, Asher Y, Himmel N, Zakay-Rones Z. Anti-trachoma activity of rifampicin and rifamycin SV derivatives. Nature 1970;225(5231):454-455.

(110) Zakay-Rones Z, Becker Y. Anti-poxvirus activity of rifampicin associated with hydrazone side chain. Nature 1970;226(5251):1162-1163.

(111) Becker Y, Zakay-Rones Z. Rifampicin - A new antitrachoma drug. Nature 1969;222(5196):851-853.

(112) Becker Y, Asher Y, Himmel N, Zakay-Rones Z, Maythar B. Rifampicin poxvirus and trachoma agent: Rifampicin Inhibition of trachoma agent in vivo. Nature 1969;224(5214):33-34.

(113) Zakay-Rones Z, Levi R, Maythar B, Becker Y. The antibody response of guinea pigs to topical and intramuscular administration of trachoma antigens. J Immunol 1969;102(5):1290-1294.

(114) Becker Y, Hochberg E, Zakay-Rones Z. Interaction of trachoma elementary bodies with host cells. Isr J Med Sci 1969;5(1):121-124.

(115) Zakay-Rones Z, Katzenelson E, Levy R. Hemagglutinin of trachoma agent. Isr J Med Sci 1968;4(2):305-306.

(116) Barron AL, Zakay-Roness Z, Bernkopf H. Hemagglutination of Chicken Erythrocytes by the Agent of Psittacosis. Proc Soc Exp Biol Med 1965;119(2):377-381.

(117) Zakay-Roness Z, Bernkopf H. Effect of Active and Ultraviolet-irradiated Inactive Vaccinia Virus on the Development of Shay Leukemia in Rats. Cancer Res 1964;24:373-378.

(118) ZAKAY-RONESS Z, ROSIN A, BERNKOFF H. A study on toxic effect of vaccinia virus in mice with special reference to hematological changes. J Immunol 1962;88:184-190.